Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other financing activities (2016 - 2025)

Anaptysbio filings provide 6 years of Other financing activities readings, the most recent being $7.4 million for Q4 2024.

  • For the quarter ending Q4 2024, Other financing activities changed N/A year-over-year to $7.4 million, compared with a TTM value of $7.5 million through Dec 2025, changed 0.48%, and an annual FY2024 reading of $7.5 million, changed N/A over the prior year.
  • Other financing activities hit $7.4 million in Q4 2024 for Anaptysbio, up from $67000.0 in the prior quarter.
  • The five-year high for Other financing activities was $7.4 million in Q4 2024, with the low at -$290000.0 in Q4 2022.
  • Median Other financing activities over the past 3 years was $39500.0 (2023), compared with a mean of $938000.0.
  • The largest YoY upside for Other financing activities was 2050.0% in 2023 against a maximum downside of 114.93% in 2023.
  • Year by year, Other financing activities stood at -$290000.0 in 2022, then soared by 85.17% to -$43000.0 in 2023, then surged by 17311.63% to $7.4 million in 2024.
  • According to Business Quant data, Other financing activities over the past three periods came in at $7.4 million, $67000.0, and $36000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.